Skip to main navigation Skip to search Skip to main content

Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes

  • Sarah Urnauer
  • , Kathrin Klutz
  • , Geoffrey K Grünwald
  • , Stephan Morys
  • , Nathalie Schwenk
  • , Christian Zach
  • , Franz-Josef Gildehaus
  • , Wolfgang Rödl
  • , Manfred Ogris
  • , Ernst Wagner
  • , Christine Spitzweg

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Article numbere2957
    Number of pages14
    JournalJournal of Gene Medicine
    Volume19
    Issue number5
    DOIs
    Publication statusPublished - May 2017

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry

    Keywords

    • Journal Article
    • IN-VIVO DELIVERY
    • cancer gene therapy
    • ONCOLYTIC VIROTHERAPY
    • nonviral gene delivery
    • LINEAR POLYETHYLENIMINE
    • sodium iodide symporter
    • LIVER-CANCER
    • radioiodine therapy
    • tumor-targeted delivery
    • RADIOIODINE THERAPY
    • PROSTATE-CANCER
    • (NIS)-MEDIATED RADIOVIROTHERAPY
    • REPORTER GENE
    • EXTENDED CIRCULATION
    • REPLICATING ADENOVIRUS

    Fingerprint

    Dive into the research topics of 'Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes'. Together they form a unique fingerprint.

    Cite this